|
Market Closed -
TEL AVIV STOCK EXCHANGE
08:54:10 04/11/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 2,235.00 ILa | +0.49% |
|
-7.15% | -1.11% |
| 06/10 | Kamada Launches Ustekinumab, Enoxaparin Biosimilars in Israel | MT |
| 06/10 | Kamada Ltd. Announces Expansion of Biosimilars Portfolio with Launch of Two Additional Products in Israel | CI |
| Market Cap | 128.98Cr 0 41Cr 36Cr 33Cr 30Cr 57Cr 3.86TCr 58Cr 398.46Cr 159.74Cr 2.04TCr 153.13Cr 149.85Cr 6.46TCr | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 128.98Cr 0 41Cr 36Cr 33Cr 30Cr 57Cr 3.86TCr 58Cr 398.46Cr 159.74Cr 2.04TCr 153.13Cr 149.85Cr 6.46TCr | EV / Sales 2026 * |
2.1x | EV / Sales 2027 * | 1.86x |
| Free-Float |
54.72% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
TEL AVIV STOCK EXCHANGE
| KMDA | Delayed | |
Nasdaq
| KMDA | Delayed | |
|
CBOE
| KMDA | Real-time |
Last Transcript: Kamada Ltd.
| 1 day | +0.49% | ||
| 1 week | -7.15% | ||
| Current month | -8.25% | ||
| 1 month | -12.04% | ||
| 3 months | +1.68% | ||
| 6 months | -7.91% | ||
| Current year | -1.11% |
| 1 week | 2,197 |  | 2,509 |
| 1 month | 2,197 | | 2,546 |
| Current year | 2,013 | | 2,890 |
| 1 year | 1,956 | | 2,890 |
| 3 years | 1,712 | | 3,045 |
| 5 years | 1,309 | | 3,045 |
| 10 years | 1,309 | | 4,500 |
| Manager | Title | Age | Since |
|---|---|---|---|
Amir London
CEO | Chief Executive Officer | 58 | 01/07/2015 |
Chaime Orlev
DFI | Director of Finance/CFO | 56 | 31/12/2017 |
Eran Nir
COO | Chief Operating Officer | 54 | 01/11/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
David Tsur
BRD | Director/Board Member | 75 | 13/12/1990 |
Leon Recanati
CHM | Chairman | 77 | 07/03/2013 |
| Chairman | 55 | 12/08/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 14/09/26 | Exercice | VP Quality | 61,323 | 0.1063% | ||
| 14/09/26 | Sell | Founder | -22,827 | 0.0396% | ||
| 14/09/26 | Exercice | General Counsel | 23,459 | 0.0407% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.49% | -7.15% | -0.97% | +25.77% | 41Cr | |
| +0.61% | +10.62% | +58.16% | +149.73% | 1,25500Cr | |
| +3.81% | +2.82% | +48.35% | +82.58% | 64TCr | |
| +3.09% | +2.95% | +39.10% | +108.48% | 51TCr | |
| +1.25% | -0.78% | +52.56% | +66.87% | 38TCr | |
| +3.93% | +6.02% | +82.28% | +45.44% | 36TCr | |
| +2.10% | +4.26% | +34.93% | +61.10% | 30TCr | |
| +1.92% | +9.37% | +13.43% | +36.55% | 29TCr | |
| +3.73% | +6.82% | +61.48% | +77.31% | 25TCr | |
| +4.19% | +9.68% | +42.96% | +113.85% | 21TCr | |
| Average | +1.63% | +1.89% | +43.23% | +76.77% | 41.86TCr | |
| Weighted average by Cap. | +1.12% | +3.90% | +50.60% | +97.78% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 61Cr 0 19Cr 17Cr 16Cr 14Cr 27Cr 1.83TCr 28Cr 189.41Cr 76Cr 970.01Cr 73Cr 71Cr 3.07TCr | 69Cr 0 22Cr 20Cr 18Cr 16Cr 31Cr 2.07TCr 31Cr 213.89Cr 86Cr 1.1TCr 82Cr 80Cr 3.47TCr |
| Net income | 8.39Cr 0 2.65Cr 2.37Cr 2.17Cr 1.97Cr 3.71Cr 250.9Cr 3.79Cr 26Cr 10Cr 132.8Cr 9.97Cr 9.75Cr 420.68Cr | 10Cr 0 3.23Cr 2.88Cr 2.64Cr 2.4Cr 4.51Cr 305.28Cr 4.61Cr 32Cr 13Cr 161.58Cr 12Cr 12Cr 511.85Cr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/26/04 | ILA 2,235.00 | +0.49% | 1,32,466 |
| 03/26/03 | ILA 2,224.00 | -3.30% | 2,64,409 |
| 02/26/02 | ILA 2,300.00 | -5.58% | 85,105 |
| 30/26/30 | ILA 2,436.00 | -0.57% | 26,177 |
| 29/26/29 | ILA 2,450.00 | -0.04% | 69,558 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- KMDA Stock
Select your edition
All financial news and data tailored to specific country editions
